GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.58 Cr | ₹1.90 Cr | ₹2.02 Cr | ₹2.50 Cr | ₹4.54 Cr |
What is the latest Total Non-Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.58 Cr |
Mar2023 | ₹1.90 Cr |
Mar2022 | ₹2.02 Cr |
Mar2021 | ₹2.50 Cr |
Mar2020 | ₹4.54 Cr |
How is Total Non-Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.58 Cr | 87.92 | |
Mar2023 | ₹1.90 Cr | -5.84 | |
Mar2022 | ₹2.02 Cr | -18.96 | |
Mar2021 | ₹2.50 Cr | -45.06 | |
Mar2020 | ₹4.54 Cr | - |
Compare Total Non-Current Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹4,233.0 Cr | 4.8% | 12.3% | 14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | 4.8% |
12.3% |
14% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses